These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 31887935

  • 1. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis.
    Chen SQ, Song YQ, Wang C, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H.
    Carbohydr Polym; 2020 Feb 15; 230():115613. PubMed ID: 31887935
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quercetin Covalently Linked Lipid Nanoparticles: Multifaceted Killing Effect on Tumor Cells.
    Chen SQ, Wang C, Song YQ, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H.
    ACS Omega; 2020 Nov 24; 5(46):30274-30281. PubMed ID: 33251462
    [Abstract] [Full Text] [Related]

  • 4. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D.
    Gastroenterology; 2010 Mar 24; 138(3):843-53.e1-2. PubMed ID: 19909746
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
    Dong K, Zhang Y, Ji HR, Guan ZL, Wang DY, Guo ZY, Deng SJ, He BY, Xing JF, You CY.
    Int J Nanomedicine; 2024 Mar 24; 19():993-1016. PubMed ID: 38299194
    [Abstract] [Full Text] [Related]

  • 6. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
    Naeem M, Oshi MA, Kim J, Lee J, Cao J, Nurhasni H, Im E, Jung Y, Yoo JW.
    Nanomedicine; 2018 Apr 24; 14(3):823-834. PubMed ID: 29353017
    [Abstract] [Full Text] [Related]

  • 7. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
    Chen G, Yang Y, Liu M, Teng Z, Ye J, Xu Y, Cai X, Cheng X, Yang J, Hu C, Wang M, Cao P.
    J Ethnopharmacol; 2015 May 26; 166():149-56. PubMed ID: 25794808
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment.
    de Oliveira Pedro R, Goycoolea FM, Pereira S, Schmitt CC, Neumann MG.
    Int J Biol Macromol; 2018 Jan 26; 106():579-586. PubMed ID: 28807690
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
    Shen C, Zhao L, Du X, Tian J, Yuan Y, Jia M, He Y, Zeng R, Qiao R, Li C.
    Mol Pharm; 2021 Mar 01; 18(3):1419-1430. PubMed ID: 33522827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B, Xu Z, Viennois E, Zhang Y, Zhang Z, Zhang M, Han MK, Kang Y, Merlin D.
    Mol Ther; 2017 Jul 05; 25(7):1628-1640. PubMed ID: 28143741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
    Cheng YH, Chang YF, Ko YC, Liu CJ.
    Int J Biol Macromol; 2021 Jun 01; 180():365-374. PubMed ID: 33676980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
    Li S, Chen L, Wang G, Xu L, Hou S, Chen Z, Xu X, Wang X, Liu F, Du YZ.
    J Nanobiotechnology; 2018 Dec 29; 16(1):105. PubMed ID: 30594254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.